226 related articles for article (PubMed ID: 33791842)
1. Identification of potential biomarkers and metabolic pathways based on integration of metabolomic and transcriptomic data in the development of breast cancer.
Yang Y; Zhu Y; Li X; Zhang X; Yu B
Arch Gynecol Obstet; 2021 Jun; 303(6):1599-1606. PubMed ID: 33791842
[TBL] [Abstract][Full Text] [Related]
2. Integration of metabolomic and transcriptomic data reveals metabolic pathway alteration in breast cancer and impact of related signature on survival.
Luo X; Yu H; Song Y; Sun T
J Cell Physiol; 2019 Aug; 234(8):13021-13031. PubMed ID: 30556899
[TBL] [Abstract][Full Text] [Related]
3. Identification of collaboration patterns of dysfunctional pathways in breast cancer.
Zhu X; Tao L; Yao J; Sun P; Pei L; Li J; Long Z; Wang Y; Zhang F
Int J Clin Exp Pathol; 2014; 7(7):3853-64. PubMed ID: 25120762
[TBL] [Abstract][Full Text] [Related]
4. Tissue-based metabolomics reveals metabolic signatures and major metabolic pathways of gastric cancer with help of transcriptomic data from TCGA.
Wang Y; Chen W; Li K; Wu G; Zhang W; Ma P; Feng S
Biosci Rep; 2021 Oct; 41(10):. PubMed ID: 34549263
[TBL] [Abstract][Full Text] [Related]
5. Integrated analysis of transcriptomic and metabolomic data demonstrates the significant role of pyruvate carboxylase in the progression of ovarian cancer.
Shang H; Zheng J; Tong J
Aging (Albany NY); 2020 Nov; 12(21):21874-21889. PubMed ID: 33177242
[TBL] [Abstract][Full Text] [Related]
6. Metabonomic-Transcriptome Integration Analysis on Osteoarthritis and Rheumatoid Arthritis.
Gao N; Ding L; Pang J; Zheng Y; Cao Y; Zhan H; Shi Y
Int J Genomics; 2020; 2020():5925126. PubMed ID: 31976312
[TBL] [Abstract][Full Text] [Related]
7. Integrated bioinformatics analysis reveals key candidate genes and pathways in breast cancer.
Wang Y; Zhang Y; Huang Q; Li C
Mol Med Rep; 2018 Jun; 17(6):8091-8100. PubMed ID: 29693125
[TBL] [Abstract][Full Text] [Related]
8. Estrogen receptor 1 and progesterone receptor are distinct biomarkers and prognostic factors in estrogen receptor-positive breast cancer: Evidence from a bioinformatic analysis.
Wu JR; Zhao Y; Zhou XP; Qin X
Biomed Pharmacother; 2020 Jan; 121():109647. PubMed ID: 31733575
[TBL] [Abstract][Full Text] [Related]
9. Identification of candidate biomarkers and pathways associated with SCLC by bioinformatics analysis.
Wen P; Chidanguro T; Shi Z; Gu H; Wang N; Wang T; Li Y; Gao J
Mol Med Rep; 2018 Aug; 18(2):1538-1550. PubMed ID: 29845250
[TBL] [Abstract][Full Text] [Related]
10. Integrative Metabolomic and Transcriptomic Analysis for the Study of Bladder Cancer.
Loras A; Suárez-Cabrera C; Martínez-Bisbal MC; Quintás G; Paramio JM; Martínez-Máñez R; Gil S; Ruiz-Cerdá JL
Cancers (Basel); 2019 May; 11(5):. PubMed ID: 31100982
[TBL] [Abstract][Full Text] [Related]
11. Metabolic fingerprinting in breast cancer stages through
Suman S; Sharma RK; Kumar V; Sinha N; Shukla Y
J Pharm Biomed Anal; 2018 Oct; 160():38-45. PubMed ID: 30059813
[TBL] [Abstract][Full Text] [Related]
12. An integrative approach based on GC-qMS and NMR metabolomics data as a comprehensive strategy to search potential breast cancer biomarkers.
Silva CL; Perestrelo R; Capelinha F; Tomás H; Câmara JS
Metabolomics; 2021 Aug; 17(8):72. PubMed ID: 34389918
[TBL] [Abstract][Full Text] [Related]
13. Integration of Transcriptome and Metabolome Provides Unique Insights to Pathways Associated With Obese Breast Cancer Patients.
Hassan MA; Al-Sakkaf K; Shait Mohammed MR; Dallol A; Al-Maghrabi J; Aldahlawi A; Ashoor S; Maamra M; Ragoussis J; Wu W; Khan MI; Al-Malki AL; Choudhry H
Front Oncol; 2020; 10():804. PubMed ID: 32509585
[TBL] [Abstract][Full Text] [Related]
14. Identification of breast cancer hub genes and analysis of prognostic values using integrated bioinformatics analysis.
Fang E; Zhang X
Cancer Biomark; 2017 Dec; 21(1):373-381. PubMed ID: 29081411
[TBL] [Abstract][Full Text] [Related]
15. Fecal Metabolic Profiling of Breast Cancer Patients during Neoadjuvant Chemotherapy Reveals Potential Biomarkers.
Zidi O; Souai N; Raies H; Ben Ayed F; Mezlini A; Mezrioui S; Tranchida F; Sabatier JM; Mosbah A; Cherif A; Shintu L; Kouidhi S
Molecules; 2021 Apr; 26(8):. PubMed ID: 33919750
[TBL] [Abstract][Full Text] [Related]
16. Screening of differentially expressed genes and identification of NUF2 as a prognostic marker in breast cancer.
Xu W; Wang Y; Wang Y; Lv S; Xu X; Dong X
Int J Mol Med; 2019 Aug; 44(2):390-404. PubMed ID: 31198978
[TBL] [Abstract][Full Text] [Related]
17. High SET Domain Bifurcated 1 (SETDB1) Expression Predicts Poor Prognosis in Breast Carcinoma.
Zhou Z; Wu B; Tang X; Yang W; Zou Q; Wang H
Med Sci Monit; 2020 Apr; 26():e922982. PubMed ID: 32305991
[TBL] [Abstract][Full Text] [Related]
18. Identification of prognostic biomarkers for breast cancer based on miRNA and mRNA co-expression network.
Yao Y; Liu R; Gao C; Zhang T; Qi L; Liu G; Zhang W; Wang X; Li J; Li J; Sun C
J Cell Biochem; 2019 Sep; 120(9):15378-15388. PubMed ID: 31037764
[TBL] [Abstract][Full Text] [Related]
19. Identification of differentially expressed genes regulated by molecular signature in breast cancer-associated fibroblasts by bioinformatics analysis.
Vastrad B; Vastrad C; Tengli A; Iliger S
Arch Gynecol Obstet; 2018 Jan; 297(1):161-183. PubMed ID: 29063236
[TBL] [Abstract][Full Text] [Related]
20. Comprehensive metabolomics expands precision medicine for triple-negative breast cancer.
Xiao Y; Ma D; Yang YS; Yang F; Ding JH; Gong Y; Jiang L; Ge LP; Wu SY; Yu Q; Zhang Q; Bertucci F; Sun Q; Hu X; Li DQ; Shao ZM; Jiang YZ
Cell Res; 2022 May; 32(5):477-490. PubMed ID: 35105939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
